NIH-funded research R01 grant

Fistula versus graft for hemodialysis access in older adults

Official title: A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial

Funded at Wake Forest University Health Sciences · NIH-11178427 · Data updated 2026-11-12

This study compares two types of surgical dialysis access—fistulas and grafts—to find which is better for adults aged 65 and older who are using a catheter for hemodialysis.

More Kidney Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2026
Funding year2025
Award (this year)$828,855
NIH project number5R01AG071803-05
Project IDNIH-11178427 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 65 or older who are receiving hemodialysis via a central venous catheter and are candidates for surgical creation of either an arteriovenous fistula or graft.

Less likely to help

People under 65, those not on hemodialysis, those who already have a functioning fistula or graft, or those who are not surgical candidates are unlikely to benefit from participation.

What this research studies

If you are 65 or older and receiving hemodialysis through a catheter, you may be randomly assigned to get either an arteriovenous fistula or a graft placed surgically. The trial is being carried out at multiple medical centers and follows participants to track infections, vascular complications, need for additional procedures, and patients' experiences. This builds on a small pilot that showed randomizing older adults to fistula versus graft is feasible and aims to enroll about 262 people to provide clearer guidance. Your regular dialysis care continues while the study team collects medical outcomes and quality-of-life information over time.

Why it matters

Potential benefit: If successful, the results could show which access type lowers infections and complications and leads to better dialysis outcomes for older adults.

How similar studies have gone: A prior small pilot trial and observational studies suggested grafts may perform better in older adults, but this is the first adequately powered randomized trial to provide definitive evidence.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Murea, Mariana — Wake Forest University Health Sciences
  • Study coordinator: Murea, Mariana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.